Hillsdale Investment Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Buy
+11,320
New +$315K 0.01% 525
2022
Q4
– Sell
-7,300
Closed -$515K – 619
2022
Q3
$515K Buy
+7,300
New +$625K 0.05% 317
2022
Q1
– Sell
-7,400
Closed -$676K – 613
2021
Q4
$676K Sell
7,400
-800
-10% -$85.8K 0.05% 321
2021
Q3
$1.05M Sell
8,200
-500
-6% -$70K 0.08% 222
2021
Q2
$1.33M Buy
+8,700
New +$1.15M 0.11% 179
2019
Q2
– Sell
-44,100
Closed -$1.51M – 670
2019
Q1
$1.51M Hold
44,100
– – 0.14% 142
2018
Q4
$1.41M Buy
44,100
+3,000
+7% +$117K 0.17% 140
2018
Q3
$1.97M Buy
41,100
+38,000
+1,226% +$1.56M 0.26% 59
2018
Q2
$96K Buy
+3,100
New +$72.5K 0.01% 298

Other funds holding STAA

Hillsdale Investment Management's STAA Position: Q2 2026 in Review

Hillsdale Investment Management opened a new position in STAAR Surgical (STAA) in Q2 2026: 11,320 shares worth $325K. The stake represents 0.01% of the portfolio and ranks #525 among its holdings. This is a return to the name: Hillsdale Investment Management previously reported a position in STAA as recently as Q3 2022.

Hillsdale Investment Management first reported a position in STAA in Q2 2018 and has held it in 9 quarters since. The position peaked at $1.97M in Q3 2018. 201 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • Hillsdale Investment Management held 11,320 shares of STAAR Surgical worth $325K as of Q2 2026.
  • STAAR Surgical was a new Hillsdale Investment Management position in Q2 2026.
  • STAAR Surgical made up 0.01% of Hillsdale Investment Management's portfolio in Q2 2026, its #525 holding.
  • Hillsdale Investment Management first reported a position in STAAR Surgical in Q2 2018 and has held it in 9 quarters since.
  • Hillsdale Investment Management's STAAR Surgical position peaked at $1.97M in Q3 2018.
  • 201 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Hillsdale Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.